A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
NCT00002401 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give delavirdine (DLV) in combination with two or three other drugs to HIV-infected patients. The drugs to be used in combination with DLV are zidovudine (ZDV), indinavir (IDV), and lamivudine (3TC).
Conditions
- HIV Infections
Interventions
- DRUG
-
Indinavir sulfate
- DRUG
-
Delavirdine mesylate
- DRUG
-
Lamivudine
- DRUG
-
Zidovudine
Sponsors & Collaborators
-
Pharmacia and Upjohn
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
NCT00002420 ·Status: TERMINATED ·Phase: PHASE2
-
Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
NCT00000810 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00002379 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
NCT00002241 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00002451 ·Status: UNKNOWN ·Phase: PHASE2
-
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
NCT00002123 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations
NCT00002430 ·Status: COMPLETED ·Phase: NA
-
A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00002410 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
NCT00002442 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient
NCT00002184 ·Status: COMPLETED ·Phase: PHASE2
-
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
NCT00000940 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs
NCT00002411 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
NCT00082394 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
NCT00001094 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine
NCT00002424 ·Status: SUSPENDED ·Phase: PHASE2
-
Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir
NCT02249130 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
NCT00002179 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
NCT00002436 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients
NCT00001084 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
NCT00002014 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
NCT00000892 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002208 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
NCT00002234 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
NCT00002426 ·Status: COMPLETED ·Phase: NA
-
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
NCT00002199 ·Status: COMPLETED ·Phase: PHASE3